계산생물학 시장 규모, 점유율 및 성장 분석 : 바이오인포매틱스 툴별, 계산 모델별, 임상 응용별, 데이터 관리 솔루션별, 조사 서비스별, 지역별 - 업계 예측(2026-2033년)

Global Computational Biology Market size was valued at USD 635.5 Million in 2024 and is poised to grow from USD 692.06 Million in 2025 to USD 1368.88 Million by 2033, growing at a CAGR of 8.9% during the forecast period (2026-2033).

The market for global computational biology is experiencing notable growth driven by the increasing integration of biological principles with mathematical and computational techniques. Key factors contributing to this expansion include the surge in drug discovery initiatives, the rising need for predictive modeling, and significant investments in population-based sequencing projects like the Human Genome Project. Advanced computational bio-modeling techniques enable precise simulation and analysis of complex biological systems, while fields like computational genetics focus on genomic homology. In neurology, 3D simulation models enhance the understanding of brain connectivity, and computational pharmacology aids in modeling intricate drug interactions. As pharmaceutical companies shift from traditional clinical trials to predictive methodologies, driven by escalating costs and drug failure rates, this sector is poised for rapid advancement, spurred by public and private R&D funding.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Computational Biology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Computational Biology Market Segments Analysis

Global Computational Biology Market is segmented by Bioinformatics Tools, Computational Models, Clinical Applications, Data Management Solutions, Research Services and region. Based on Bioinformatics Tools, the market is segmented into Genomic Analysis and Proteomics Tools. Based on Computational Models, the market is segmented into Systems Biology and Predictive Modeling. Based on Clinical Applications, the market is segmented into Drug Discovery and Personalized Medicine. Based on Data Management Solutions, the market is segmented into Data Storage and Data Integration. Based on Research Services, the market is segmented into Consulting Services and Outsourced Research. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Computational Biology Market

The Global Computational Biology market is experiencing growth driven by the increasing availability of advanced computational tools for genome sequencing. These tools aid in numerous tasks, such as creating PCR primers, identifying restriction enzyme cut sites, and converting DNA sequences into amino acid sequences. As databases expand and sequence analysis software becomes more accessible, researchers can effortlessly access vast information regarding gene structures and their encoded messages. Computational techniques enhance drug development by efficiently identifying functionally significant protein sequences within large datasets. For example, discovering protein targets in microbial genomes can lead to breakthroughs in disease treatment and the development of commercially valuable enzymes, making computer-based predictions crucial for identifying key proteins from extensive genetic resources.

Restraints in the Global Computational Biology Market

The global computational biology market faces significant constraints primarily due to a shortage of skilled professionals and a lack of standardization in the field. Proficiency in programming, mathematics, statistics, and a robust understanding of both cloud computing and biological sciences are essential for success in computational biology. However, the interdisciplinary nature of the field contributes to the absence of a defined educational framework, which can impede the development of skills among emerging graduates. Furthermore, the absence of established methodologies for addressing complex challenges, such as allergic reactions and postoperative complications, is likely to restrict revenue growth in the market.

Market Trends of the Global Computational Biology Market

The global computational biology market is experiencing robust growth driven by an increasing focus on pharmacogenomics and the rise in clinical studies aimed at understanding the genetic diversity among patient populations. This trend enhances knowledge of biological pathways and genomic factors, thereby accelerating drug discovery and research timelines. Demand is further fueled by advancements in epigenomics, proteomics, and metagenomics, facilitating deeper insights into protein structures and interactions. Additionally, significant technological innovations in disease modeling and drug development, coupled with rising investments from both private and public sectors in research and development, are poised to sustain market expansion and evolution.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Computational Biology Market Size by Bioinformatics Tools & CAGR (2026-2033)

• Market Overview
• Genomic Analysis
  • Sequencing Tools
  • Variant Analysis
• Proteomics Tools
  • Protein Structure Analysis
  • Mass Spectrometry Software

Global Computational Biology Market Size by Computational Models & CAGR (2026-2033)

• Market Overview
• Systems Biology
  • Network Modeling
  • Pathway Analysis
• Predictive Modeling
  • Machine Learning Models
  • Statistical Models

Global Computational Biology Market Size by Clinical Applications & CAGR (2026-2033)

• Market Overview
• Drug Discovery
  • Target Identification
  • Clinical Trials Analytics
• Personalized Medicine
  • Genetic Profiling
  • Therapeutic Outcomes

Global Computational Biology Market Size by Data Management Solutions & CAGR (2026-2033)

• Market Overview
• Data Storage
  • Cloud Storage Systems
  • Database Management Systems
• Data Integration
  • Interoperability Solutions
  • Data Workflow Automation

Global Computational Biology Market Size by Research Services & CAGR (2026-2033)

• Market Overview
• Consulting Services
  • Technical Consulting
  • Regulatory Compliance
• Outsourced Research
  • Laboratory Services
  • Analytical Services

Global Computational Biology Market Size & CAGR (2026-2033)

• North America (Bioinformatics Tools, Computational Models, Clinical Applications, Data Management Solutions, Research Services)
  • US
  • Canada
• Europe (Bioinformatics Tools, Computational Models, Clinical Applications, Data Management Solutions, Research Services)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Bioinformatics Tools, Computational Models, Clinical Applications, Data Management Solutions, Research Services)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Bioinformatics Tools, Computational Models, Clinical Applications, Data Management Solutions, Research Services)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Bioinformatics Tools, Computational Models, Clinical Applications, Data Management Solutions, Research Services)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sage BioNetworks
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BERG Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioinformatics Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genomatica
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GRAIL
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Strateos
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Benchling
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioSymetrics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evotec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Convergent Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Adaptive Biotechnologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insilico Medicine
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synlogic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genomatix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alethia Biotherapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recursion Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accellix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations